C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 123 filers reported holding C4 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $34,741 | -99.2% | 11,081 | -98.5% | 0.00% | -100.0% |
| Q4 2022 | $4,357,879 | -39.4% | 738,629 | -54.9% | 0.00% | -40.0% |
| Q3 2022 | $7,188,181 | +12.2% | 1,637,494 | +92.7% | 0.01% | +25.0% |
| Q2 2022 | $6,406,000 | -75.7% | 849,600 | -21.8% | 0.00% | -69.2% |
| Q1 2022 | $26,368,000 | -21.7% | 1,086,782 | +3.9% | 0.01% | -7.1% |
| Q4 2021 | $33,682,000 | -28.1% | 1,045,945 | -0.3% | 0.01% | -30.0% |
| Q3 2021 | $46,867,000 | +9.3% | 1,048,888 | -7.4% | 0.02% | +11.1% |
| Q2 2021 | $42,883,000 | -7.7% | 1,133,129 | -12.5% | 0.02% | -14.3% |
| Q1 2021 | $46,462,000 | +15.1% | 1,295,590 | -0.2% | 0.02% | +10.5% |
| Q4 2020 | $40,370,000 | – | 1,297,609 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |